Compare CHKP & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHKP | CNC |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 18.7B |
| IPO Year | 1996 | 2001 |
| Metric | CHKP | CNC |
|---|---|---|
| Price | $188.52 | $39.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 24 | 17 |
| Target Price | ★ $231.41 | $40.06 |
| AVG Volume (30 Days) | 1.0M | ★ 6.0M |
| Earning Date | 01-29-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.68 | N/A |
| EPS | ★ 9.12 | N/A |
| Revenue | $2,684,200,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $8.42 | $32.54 |
| Revenue Next Year | $6.01 | $0.19 |
| P/E Ratio | $20.67 | ★ N/A |
| Revenue Growth | 6.31 | ★ 14.57 |
| 52 Week Low | $178.64 | $25.08 |
| 52 Week High | $234.36 | $66.81 |
| Indicator | CHKP | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 57.92 |
| Support Level | $185.19 | $38.58 |
| Resistance Level | $191.77 | $40.15 |
| Average True Range (ATR) | 4.40 | 1.26 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 22.64 | 58.80 |
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.